Evidence map›Paper›PMID 42263051›Full record

Observational studyKidney & blood pressure research2026

ATHENA Study - The Role of Circulating Plasma MicroRNAs in Paediatric Patients with Untreated Primary Hypertension: Baseline Expression and Exercise-Induced Changes.

Michał Szyszka, Ceren Eyileten, Jolanta Małyszko, Karolina Skubisz, Radosław Pietrzak, Hubert Krysztofiak, Piotr Skrzypczyk

Abstract readObservational Study
In one paragraph

Observational study in Kidney & blood pressure research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Michał SzyszkaDepartment of Pediatrics and Nephrology, Doctoral School, Medical University of Warsaw, Warsaw, Poland.
Ceren EyiletenDepartment of Experimental and Clinical Pharmacology, Medical University of Warsaw, Center for Preclinical Research and Technology CEPT, Warsaw, Poland.
Jolanta MałyszkoDepartment of Nephrology, Dialysis and Internal Medicine, Medical University of Warsaw, Warsaw, Poland, jmalyszko@gmail.com.
Karolina SkubiszDepartment of Laboratory Diagnostics and Clinical Immunology of Developmental Age, Pediatric Hospital of Medical University of Warsaw, Warsaw, Poland.
Radosław PietrzakDepartment of Pediatric Cardiology and General Pediatrics, Medical University of Warsaw, Warsaw, Poland.
Hubert KrysztofiakMossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland.
Piotr SkrzypczykDepartment of Pediatrics and Nephrology, Medical University of Warsaw, Warsaw, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe role of microRNA in primary hypertension (PH) remains unclear. This study examined the expression of microRNA-16, -21, -27a, -27b, -133a, and -145 in untreated hypertensive children, their response to aerobic exercise, and correlations with blood pressure (BP) and related parameters.

methodsA pre-post observational, hypothesis-generating study included 56 hypertensive (study group [SG]) and 59 healthy children (control group [CG]). Plasma microRNA levels and clinical, biochemical, BP, vascular, and hypertension-mediated organ damage (HMOD) parameters were assessed before and after one session of standardized aerobic exercise.

resultsThe baseline relative microRNA-27b (p < 0.001) and microRNA-133a (p = 0.018) expressions were significantly lower in the SG; similarly, after an exercise bout. After an exercise bout, the expression of microRNA-27b, -133a, and -145 increased in CG, whereas only the expression of microRNA-145 increased in SG. In SG, microRNA-16, -21, -27a, and -145 correlated positively with pre-exercise BP. There were no correlations between the analysed microRNA particles and parameters of HMOD. ROC analysis identified the best prognostic profile for relative microRNA-27b expression as a potential biomarker of the absence of PH. Multivariate analysis revealed the relative microRNA-16 expression as the only significant predictor of elevated diastolic BP.

conclusionsMicroRNA-27b and microRNA-133a are underexpressed in children with PH. These particles may represent potential markers of hypertension in children and may also be associated with a lower burden of hypertension-related alterations. MicroRNA-16 may serve as a marker of diastolic hypertension.

Indexed as

Circulating MicroRNAEssential HypertensionExerciseHypertensionMicroRNAsAdolescentBiomarkersBlood PressureChildFemaleHumansMaleBiomarkersCirculating MicroRNAMicroRNAsAdolescentsAerobic exerciseHypertension-mediated organ damageMicroRNAPrimary hypertension

Identifiers

PMID42263051
PMCPMC13363113

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.